MAPK4 may play a key role in triple-negative breast cancer

[News]

Scientific evidence supporting the involvement of the enzyme MAPK4 in cancer growth and resistance to certain therapies has been growing quickly. In a current study published in the journal Nature Communications, a team at Baylor College of Medicine and collaborating institutions reports that MAPK4 seems to play an important role in triple-negative breast cancer (TNBC), a devastating disease with limited therapeutic options.

More... (https://www.news-medical.net/news/20220112/MAPK4-may-play-a-key-role-in-triple-negative-breast-cancer.aspx)